Company Filing History:
3 out of 1,220 
2 out of 444 
2 out of 1,035 
Years Active: 1982-2009
Title: Allan Lipton: Innovator in Cancer Monitoring and Treatment
Introduction
Allan Lipton is a notable inventor based in Hershey, PA (US), recognized for his contributions to cancer patient monitoring and treatment. He holds a total of 7 patents, showcasing his commitment to advancing medical science and improving patient outcomes.
Latest Patents
One of Lipton's latest patents focuses on assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte. This invention describes methods for monitoring the progression of disease or the effectiveness of cancer treatment by measuring the ECD levels in body fluid samples. A decrease in ECD levels compared to normal control individuals serves as an indicator of cancer advancement or treatment effectiveness. Another significant patent involves a pharmaceutical composition for treating malignancies, which combines bisphosphonates, a COX-2 inhibitor, and taxol. This composition is designed for patients suffering from malignant diseases associated with bone metastases or excessive bone resorption.
Career Highlights
Throughout his career, Allan Lipton has worked with esteemed organizations, including the Penn State Research Foundation and Research Incorporated. His work has significantly impacted the field of oncology, particularly in developing innovative methods for cancer treatment and monitoring.
Collaborations
Lipton has collaborated with notable colleagues, including Lois Mary Witters and C. Frank Bennett, contributing to the advancement of cancer research and treatment methodologies.
Conclusion
Allan Lipton's innovative work in cancer monitoring and treatment exemplifies his dedication to improving patient care through scientific advancements. His patents reflect a deep understanding of the complexities of cancer and a commitment to finding effective solutions.